3 Days
Source:
اليوم السابع
اليوم السابع
Ready to play
Ready to play
The first human clinical trial has been launched to test a treatment aimed at reprogramming and regenerating the body's cells to combat the effects of aging. The company "Life Biosciences" is using the treatment "ER-100," inspired by the research of Japanese scientist Shinya Yamanaka, which targets resetting the biological age of damaged cells. The study focuses on assessing the safety of the treatment and its ability to restore cellular functions, particularly in cases of age-related eye cell damage, with a long-term follow-up plan of up to five years to monitor the effects.
Notice: This Is an AI-Generated Summary
Comments (0)